Aiping Zhou
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College · Department of oncology, Cancer hospital of Chinese Academy of Medical Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aiping Zhou as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07286695 · Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · not yet recruiting · Metastatic Colorectal Cancer (CRC), Colorectal Cancer · principal investigator
- Ph2NCT06543836 · ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · unknown · Metastatic Colorectal Cancer · principal investigator
- Ph1/Ph2NCT06500676 · A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D MutationsGenfleet Therapeutics (Shanghai) Inc. · recruiting · KRAS G12D Mutations, Advanced Solid Tumors · principal investigator
- Ph1/Ph2NCT06031584 · A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Her2-positive/Low-expression Urinary and Digestive Tract Tumors · principal investigator
- Ph2NCT05934331 · A LM-302 Combination With Other Anti-Tumor Therapies Phase ll StudyLaNova Medicines Zhejiang Co., Ltd. · recruiting · Malignant Neoplasms of Digestive Organs · principal investigator
- Ph3NCT05754853 · A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial CancerShanghai Miracogen Inc. · recruiting · Advanced or Metastatic Urothelium Cancer · principal investigator
- Ph1NCT05499715 · A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid TumorsChinese Academy of Medical Sciences · unknown · Advanced Tumor of Digestive Tract or Urinary System · principal investigator
- Ph2NCT05188209 · A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.Lepu Biopharma Co., Ltd. · terminated · Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma · principal investigator
- Ph2NCT05141747 · A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.Shanghai Miracogen Inc. · unknown · Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer · principal investigator
- Ph3NCT05074966 · The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC PtsChinese Academy of Medical Sciences · unknown · Colo-rectal Cancer · principal investigator
- Ph2NCT04838964 · A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract CancerLepu Biopharma Co., Ltd. · completed · Advanced or Metastatic Biliary Tract Cancer · principal investigator
- Ph2NCT04839510 · A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium CancerShanghai Miracogen Inc. · unknown · Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma · principal investigator
- N/ANCT04835324 · Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world StudyChinese Academy of Medical Sciences · unknown · Advanced Colorectal Cancer · principal investigator
- Ph2NCT04837508 · A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract CancerShanghai Miracogen Inc. · unknown · Advanced or Metastatic Biliary Tract Cancer · principal investigator
- Ph2NCT04694404 · Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric CancerAiping Zhou · unknown · S-1 Plus Oxaliplatin · study director
- Ph1NCT04072679 · Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular CarcinomaChinese Academy of Medical Sciences · completed · Advanced Hepatocellular Carcinoma · principal investigator
- Ph2NCT03443661 · Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal CancerAiping Zhou · completed · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT03415802 · Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerAiping Zhou · completed · Advanced Pancreatic Cancer · principal investigator
- Ph1NCT03286244 · Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric CancerAnewPharma · unknown · Advanced Gastric Cancer · study chair
- Ph1NCT01832298 · Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid TumorHaihe Biopharma Co., Ltd. · completed · Advanced Solid Tumor · principal investigator
- Ph2NCT01747707 · Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerChinese Academy of Medical Sciences · unknown · Gastric Cancer, Gastroesophageal Junction Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:00 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).J Clin Oncol · 2022435 citationsRCR 35.8
- Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors.J Hematol Oncol · 2021133 citationsRCR 6.3
- Effects of Dexmedetomidine on Patients Undergoing Laparoscopic Surgery for Colorectal Cancer.J Surg Res · 202118 citationsRCR 1.5
- 12 citationsRCR 1.3
- Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.Int J Radiat Oncol Biol Phys · 20084 citationsRCR 0.0
- Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR/MSS refractory metastatic colorectal cancer: a phase 2 clinical trial.Cancer Immunol Immunother · 20254 citationsRCR 1.0
- [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].Zhonghua Zhong Liu Za Zhi · 20222 citationsRCR 0.2
- Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study.Drug Des Devel Ther · 20251 citationsRCR 0.2